Sinon Corporation (1712) Fair Value & Analysis
Basic Materials · TW · Market cap 16.7B TWD
Analysis
Sinon Corporation (1712) currently trades at 39.15 TWD, while our model-based Fair Value estimate is 44.21 TWD — implying the stock looks roughly 12.9% undervalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Sinon Corporation manufactures and sells various chemicals and fertilizers. The company offers crop protection products, such as agrochemicals, fertilizers, farming materials, seeds, and seedlings, etc. It also provides product design, mold design and manufacturing, blow molding, injection molding, PET injection molding, PET extrusion blow molding, one-step injection blow molding, printing, gilding, labeling, shrink sleeving, etc. In addition, the company engages in the orchid business; houseware, catering services, and retail of agricultural products; manufacture and sale of cement; manufacture, import, and export of medical and chemical products; design and sale of software; food and special crops; retail sale of tobacco and alcoholic drinks; operation of supermarket; software design and information security maintenance; and smart agriculture system cloud services, integrated agricultural planning, and carbon reduction planning services. The company was formerly known as Shinung C…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.